Pacira BioSciences, Inc.

Pacira BioSciences, Inc.verified

PCRX

Price:

$23.98

Market Cap:

$1.09B

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira Bi...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2011-02-03

Stock Exchange

NASDAQ

Ticker

PCRX

The Current Ratio as of December 2025 (TTM) for Pacira BioSciences, Inc. (PCRX) is 5.26

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.26. This represents a change of 68.78% compared to the average of 3.11 of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical Current Ratio (quarterly & annually)

How has PCRX Current Ratio performed in the past?

The mean historical Current Ratio of Pacira BioSciences, Inc. over the last ten years is 4.10. The current 5.26 Current Ratio has changed 12.73% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Current Ratio was at its highest in in the March 2017 quarter at 9.81. The Current Ratio was at its lowest in in the September 2016 quarter at 1.60.

Quarterly (TTM)
Annual

Average

4.10

Median

3.58

Minimum

1.66

Maximum

7.88

Pacira BioSciences, Inc. (PCRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 225.56%

Maximum Annual Current Ratio = 7.88

Minimum Annual Increase = -54.09%

Minimum Annual Current Ratio = 1.66

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.40-54.09%
20235.2455.30%
20223.37102.92%
20211.66-35.39%
20202.57-32.21%
20193.79-51.84%
20187.8813.26%
20176.9628.33%
20165.42225.56%
20151.678.82%

Pacira BioSciences, Inc. (PCRX) Average Current Ratio

How has PCRX Current Ratio performed in the past?

The current Current Ratio of Pacira BioSciences, Inc. (PCRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.67

5-year avg

3.05

10-year avg

4.10

Pacira BioSciences, Inc. (PCRX) Current Ratio vs. Peers

How is PCRX’s Current Ratio compared to its peers?

Pacira BioSciences, Inc.’s Current Ratio is less than Cronos Group Inc. (24.65), less than AnaptysBio, Inc. (8.68), less than Xencor, Inc. (5.34), greater than Oculis Holding AG (4.55), greater than UroGen Pharma Ltd. (4.14), greater than Kodiak Sciences Inc. (1.78), greater than Tandem Diabetes Care, Inc. (2.44), less than BridgeBio Oncology Therapeutics Inc. (13.33), greater than Mind Medicine (MindMed) Inc. (3.30), greater than Phathom Pharmaceuticals, Inc. (2.23),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Pacira BioSciences, Inc.'s Current Ratio?

How is the Current Ratio calculated for Pacira BioSciences, Inc. (PCRX)?

What is the highest Current Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 3-year average Current Ratio for Pacira BioSciences, Inc. (PCRX)?

What is the 5-year average Current Ratio for Pacira BioSciences, Inc. (PCRX)?

How does the current Current Ratio for Pacira BioSciences, Inc. (PCRX) compare to its historical average?